It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Looking for low-effort income? Check out ways to make money with minimal effort and maximize your earnings without a lot of work.
14,428 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
SK Hynix moves to list in the U.S., challenging Micron for memory-chip dominance as AI-driven demand and cyclical dyn...
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Jim Cramer has spotlighted a widening valuation gap between NVIDIA and SanDisk, calling it the 'most insulting trade'...
London-based Valarian secures a $50 million Series A led by NEA to deploy ACRA, a sovereignty-focused layer that lets...
Google Gemini AI projects a sharp, liquidity-driven Bitcoin rally to as high as $150,000 by the end of 2026, undersco...
A memory-focused stock surged from about $40 to near $2,000 this year, fueling debate over whether the run can endure...
Bitcoin and Ethereum jumped after cooler-than-expected U.S. inflation data, while Japan’s Upper House committee advan...
Rising financed jewelry debt is reshaping family budgets and investment plans. Experts say debt consolidation seldom ...
Netflix is set to release its Q2 earnings after the bell tonight, with investors watching ad revenue growth, content ...
A new mega-listing grabbed headlines by raising $26.5 billion, ranking just below SpaceX in U.S. market history. Read...
Berkshire Hathaway is changing under Greg Abel, shifting toward concentrated bets on Apple and Alphabet. This article...